FAQ
Here are some Frequently Asked Questions.
Covers prescriptions, how to order, refills, shipping, cold-chain packaging for injectables, and accepted payment types including HSA/FSA.
All medications we carry are FDA-approved and have been evaluated through rigorous clinical trials for safety and efficacy. That said, every medication has potential side effects and contraindications. It is essential that you have an honest conversation with your healthcare provider about your full medical history, current medications, and any health conditions before starting any new treatment.
Yes, and in some cases your physician may prescribe the diabetes-indicated version of the same drug (for example, Mounjaro instead of Zepbound) if it offers better insurance coverage for your situation. Always discuss your full medication list with your provider, as dose adjustments may be needed for diabetes medications taken alongside GLP-1 therapies.
The most commonly reported side effects are gastrointestinal and include nausea, vomiting, diarrhea, constipation, and stomach discomfort. These are most common during the early weeks of treatment and during dose increases. They typically improve over time. Eating smaller meals, avoiding fatty or heavily spiced foods, and staying hydrated can help reduce these effects.
Foundayo (orforglipron) is an oral GLP-1 receptor agonist taken once daily as a tablet. Unlike injectable medications such as Wegovy or Zepbound, it requires no injections and no refrigeration, making it a convenient alternative for patients who prefer oral therapy. It is FDA-approved for chronic weight management in adults with obesity or overweight with a weight-related health condition.
Both contain tirzepatide the exact same active ingredient. Mounjaro is FDA-approved for type 2 diabetes management, while Zepbound is FDA-approved for chronic weight management. Your physician will prescribe the appropriate version based on your diagnosis and insurance coverage.
Both are FDA-approved for chronic weight management, but they contain different active ingredients. Zepbound contains tirzepatide, which activates both GLP-1 and GIP receptors (dual agonist), while Wegovy contains semaglutide, which activates GLP-1 receptors only. In clinical trials, tirzepatide produced greater average weight loss than semaglutide, though individual responses vary. Your provider can help determine which is right for you.
We carry a range of FDA-approved prescription medications for chronic weight management, including injectable GLP-1 and dual GIP/GLP-1 receptor agonists (such as tirzepatide and semaglutide) as well as oral options. Our full catalog is available in the Weight Loss category on our site.
Temperature-sensitive medications like tirzepatide and semaglutide injections are packed in insulated coolers with medical-grade cold packs designed to maintain safe temperatures for 48–72 hours in transit.
No. You can have drugs on the website without a prescription except for some crucial cases such as treatments for low blood sugar levels, based on the info you share with us.
Browse our medication categories, select your medication, and proceed to checkout. You’ll be asked to upload your prescription or authorize us to contact your prescribing provider directly in some rare cases. After that or Once your prescription is verified, your order will be processed and shipped.
Yes. Once your prescription is on file and valid, or you’re simply a returning client then you are previleged with refills and often at a reasonable discount.
We ship to almost all U.S. states. Certain states have specific pharmacy regulations that may affect shipping eligibility.
We also ship discreetly only on request. This is out of the normal shipping and it’s dependent on your location.
Standard shipping typically takes 3–5 business days.
Medications that require refrigeration (such as injectable GLP-1 pens) are shipped in insulated packaging with cold packs to maintain the required temperature during transit.
